×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BILCARE LTD. | NA | NA | NA | NA | 193.0 | 31.2 |
| PANCHSHEEL ORGANICS LTD. | NA | NA | NA | NA | 193 | 14.4 |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 190 | 45.7 |
Bilcare Ltd., with Security Code 526853, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 151.0 | 4.6 | 3.7 | 4.6 | 5.1 | 4.3 | 4.9 | 2.8 | 3.4 | 4.1 |
| Expenses | 140.0 | 9.0 | 5.1 | 6.6 | 6.3 | 8.7 | 5.7 | 5.5 | 3.9 | 5.6 |
| Operating Profit | 11.0 | -4.4 | -1.5 | -2.1 | -1.2 | -4.4 | -0.9 | -2.7 | -0.5 | -1.5 |
| OPM % | 7.26% | -94.37% | -39.62% | -44.66% | -24.11% | -102.33% | -17.45% | -98.91% | -15.77% | -36.56% |
| Other Income | -6.4 | 516.0 | 15.7 | 6.1 | 0.3 | 5.2 | 3.8 | 3.8 | 3.8 | 6.5 |
| Interest | 15.4 | 0.2 | 0.2 | 0.1 | 0.2 | 2.1 | 0.6 | 3.0 | 0.1 | 0.1 |
| Depreciation | 8.8 | 1.7 | 0.4 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.6 |
| Profit before tax | -15.0 | -6.8 | -1.4 | 3.5 | -1.6 | -5.6 | 1.6 | -2.8 | 2.4 | 4.3 |
| Tax % | -4.6% | -22.7% | -1.7% | -215.8% | -5.5% | 34.6% | -14.1% | -6.9% | -23.7% | -19% |
| Net Profit | -18.8 | 399.1 | 13.4 | -4.0 | -1.6 | -2.5 | 1.4 | -2.6 | 1.8 | 3.4 |
| EPS in Rs | -7.97 | 169.5 | 5.7 | -1.72 | -0.66 | -1.06 | 0.59 | -1.09 | 0.76 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 245.9 | 233.5 | 182.3 | 189.9 | 174.9 | 200.1 | 194.1 | 201.7 | 198.1 | 194.0 |
| Expenses | 233.8 | 219.2 | 168.8 | 173.2 | 157.7 | 208.3 | 175.2 | 194.1 | 187.5 | 186.6 |
| Operating Profit | 12.0 | 14.3 | 13.5 | 16.7 | 17.3 | -8.3 | 18.9 | 7.7 | 10.7 | 7.4 |
| OPM % | 4.89% | 6.14% | 7.38% | 8.79% | 9.86% | -4.13% | 9.76% | 3.79% | 5.38% | 3.81% |
| Other Income | -6.5 | 231.4 | 2.8 | 8.5 | 3.8 | 8.8 | 3.7 | -6.0 | -6.5 | 21.2 |
| Interest | 16.4 | 11.4 | 19.0 | 19.7 | 20.5 | 22.6 | 20.9 | 23.7 | 19.5 | 18.5 |
| Depreciation | 9.6 | 9.3 | 10.5 | 10.5 | 10.6 | 13.4 | 11.5 | 11.0 | 11.7 | 11.6 |
| Profit before tax | -13.5 | -2.2 | -12.5 | -3.3 | -10.1 | -39.2 | -9.7 | -23.2 | -17.1 | -15.3 |
| Tax % | -5.9% | -65.2% | -1.2% | 147.3% | 34.1% | -44.5% | 55% | -9.5% | -39.9% | 0% |
| Net Profit | -19.2 | 78.3 | -13.1 | -12.2 | -13.5 | -19.7 | -15.0 | -29.9 | -16.3 | 5.0 |
| EPS in Rs | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -27% |
| 5 Years: | -41% |
| 3 Years: | -61% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 26% |
| 3 Years: | 3% |
| 1 Year: | 18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -24% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 0% |
| TTM: | -98% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 26% |
| 3 Years: | 3% |
| 1 Year: | 18% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|